January 6, 2023

Family Policy Alliance to Pharmacies: Don’t Supply Abortion Pills

The U.S. FDA will now allow the pills to be dispensed at pharmacies – but that doesn’t mean they should

The United States Food and Drug Administration (FDA) announced on Tuesday that it will allow the abortion pill, mifepristone, to be dispensed at retail pharmacies and eliminated the requirement for in-person distribution of these pills. Pharmacies distributing these pills and physicians prescribing will need to apply through the FDA in order to begin providing abortion pills.

But Family Policy Alliance is calling on pharmacies not to dispense the pills.

Statement from Ruth Ward, Director of Government Affairs for Family Policy Alliance:

“The FDA may have given the green light for pharmacies to dispense abortion pills, but that doesn’t mean pharmacies should dispense them. In fact, we’re calling on pharmacies large and small not to dispense these dangerous drugs.

“Abortion drugs are a health and safety threat to women and their children. Millions of women all over the country are being told these drugs are safe when the exact opposite is true. Not only do these pills increase women’s risk of life-threatening complications, but they also end the life of the unborn child by a gruesome death at home, away from any medical supervision.

“Pharmaceutical drugs are intended to make us whole and assist with pain, not to electively end the life of a valuable, growing child in the womb. The FDA has again sadly put politics over the health of women, and it will be up to pharmacies, physicians and elected leaders to reject these setbacks on safety.”

Individuals can use Family Policy Alliance’s Action Center to send a short message to several major U.S. pharmacies and grocery stores. They may also use this message to share with their local pharmacies.


  • Mifepristone was approved for use in 2000 and is a two-dose abortion pill used by a woman seeking to end her pregnancy for any reason up to 10 weeks gestation.
    • The first dose starves the unborn child of hormones needed to develop.
    • The second dose causes the child to be expelled from the uterus while the woman is away from medical supervision.
  • As of June 2022, there were 28 reported maternal deaths and over 4,200 reported adverse effects, including hemorrhaging and infections. (Source: https://www.fda.gov/media/164331/download)
  • In 2022, nearly half of the states have introduced common sense legislation limiting access to abortion pills.
  • Research has shown that abortion pills put women at heightened physical and mental health risks. Women who use abortion pills are 50 percent more likely to visit an ER than with a surgical abortion, and as many as one out of five women will suffer a complication and can result in a surgical procedure to remove the unborn child if unsuccessful. (Source: https://lozierinstitute.org/fact-sheet-risks-and-complications-of-chemical-abortion/#_edn1)
  • By removing the in-person requirement for distribution, this only further undermines the medical needs of women seeking care during a critical time in their life as well as opens the door for women to be coerced into having an abortion.

Media Contact:

Robert Noland, (719) 308-2822, Media@FamilyPolicyAlliance.com


Family Policy Alliance advances biblical citizenship and promotes public policy that protects religious freedom, families, and life.

Related Press Releases

Stay connected with email updates

Unleash your citizenship! Get news, commentary and alerts delivered right to your inbox.